Multicenter Studies as Topic

"Multicenter Studies as Topic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Works about controlled studies which are planned and carried out by several cooperating institutions to assess certain variables and outcomes in specific patient populations, for example, a multicenter study of congenital anomalies in children.

Descriptor ID	D015337
MeSH Number(s)	E05.318.760.658 N05.715.360.775.508 N06.850.520.450.643
Concept/Terms	Multicenter Studies as Topic Multicenter Studies as Topic Multicentre Studies as Topic Multicenter Trials Multicenter Trials Multicenter Trial Trial, Multicenter Trials, Multicenter Multicentre Trials Multicentre Trial Trial, Multicentre Trials, Multicentre

Below are MeSH descriptors whose meaning is more general than "Multicenter Studies as Topic".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Investigative Techniques [E05]
Epidemiologic Methods [E05.318]
Epidemiologic Study Characteristics [E05.318.760]
Multicenter Studies as Topic [E05.318.760.658]
Health Care [N]
Health Care Quality, Access, and Evaluation [N05]
Quality of Health Care [N05.715]
Health Care Evaluation Mechanisms [N05.715.360]
Epidemiologic Study Characteristics [N05.715.360.775]
Multicenter Studies as Topic [N05.715.360.775.508]
Environment and Public Health [N06]
Public Health [N06.850]
Epidemiologic Methods [N06.850.520]
Epidemiologic Study Characteristics [N06.850.520.450]
Multicenter Studies as Topic [N06.850.520.450.643]

Below are MeSH descriptors whose meaning is related to "Multicenter Studies as Topic".

Below are MeSH descriptors whose meaning is more specific than "Multicenter Studies as Topic".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Multicenter Studies as Topic" by people in this website by year, and whether "Multicenter Studies as Topic" was a major or minor topic of these publications.

Bar chart showing 101 publications over 28 distinct years, with a maximum of 10 publications in 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	0	2	2
1996	0	1	1
1998	0	1	1
2000	0	1	1
2001	0	1	1
2002	0	3	3
2003	0	2	2
2004	0	1	1
2005	0	2	2
2006	0	1	1
2007	1	8	9
2008	1	6	7
2009	0	3	3
2010	0	2	2
2011	1	5	6
2013	1	1	2
2014	1	4	5
2015	0	3	3
2016	0	5	5
2017	1	3	4
2018	0	4	4
2019	0	4	4
2020	2	8	10
2021	0	4	4
2022	0	5	5
2023	0	5	5
2024	0	3	3
2025	0	5	5

Below are the most recent publications written about "Multicenter Studies as Topic" by people in Profiles.

Wainer AL, Edmunds SR, Carter AS, Stone WL, Sheldrick RC, Broder-Fingert S, Stern YS, Harrington E, V Ibanez L, Ingersoll B. A hybrid type I randomized effectiveness-implementation trial of a Naturalistic Developmental Behavioral Intervention in the Part C early intervention system: study protocol. BMC Pediatr. 2025 Apr 01; 25(1):263.

View in: PubMed
Ogdie A, Reddy SM, Gillespie SH, Husni ME, Scher JU, Salomon-Escoto K, Kay J, Luedders BA, Curtis JR, Shields AJS, Chakravarty SD, Gong C, Walsh JA. Guselkumab versus golimumab in patients with active psoriatic arthritis and inadequate response to an initial tumor necrosis factor inhibitor: study protocol for EVOLUTION, a pragmatic, phase 3b, open-label, randomized, controlled effectiveness trial. Trials. 2025 Mar 19; 26(1):96.

View in: PubMed
Zhang J, Hobbs BD, Silverman EK, Sparrow D, Ortega VE, Xu H, Zhang C, Dupuis J, Walkey AJ, O'Connor GT, Cho MH, Moll M. Polygenic Risk Score Added to Conventional Case Finding to Identify Undiagnosed Chronic Obstructive Pulmonary Disease. JAMA. 2025 Mar 04; 333(9):784-792.

View in: PubMed
Charlson ME, Mittleman I, Ramos R, Cassells A, Lin TJ, Eggleston A, Wells MT, Hollenberg J, Pirraglia P, Winston G, Tobin JN. Preventing "tipping points" in high comorbidity patients: A lifeline from health coaches - rationale, design and methods. Contemp Clin Trials. 2025 May; 152:107865.

View in: PubMed
Decker SE, Kroll-Desrosiers A, Mattocks KM, Aunon FM, Galliford E, DeRycke EC, Doran N, Baird S, Rielage JK, Ridley J, Bannister J, Giovannelli TS, Fuehrlein BS, Shriver C, Spana E, Honsberger M, Demirelli SA, Shest E, Landes SJ, Goodman M, Martino S. Study protocol of a hybrid type 1 effectiveness-implementation multisite trial: Dialectical behavior therapy skills group for Veterans at high-risk for suicide attempt. Contemp Clin Trials. 2025 Apr; 151:107828.

View in: PubMed
Sellinger JJ, Rosen MI, Lazar CM, Gilstad-Hayden K, Dziura J, Li FY, Mattocks K, Weede A, Sullivan-Tibbs M, Rose L, Garcia Vassallo G, Manhapra A, Turner A, Vogt D, Woodward EN, Hartmann CW, Haskell SG, Mohammad A, Martino S. Screening, brief intervention, and referral to treatment for pain management for veterans separating from military service: study protocol of a hybrid type 2 study testing implementation facilitation versus training-as-usual. Pain Med. 2024 Nov 01; 25(Supplement_1):S99-S106.

View in: PubMed
Ingersoll B, Espinel A, Nauman J, Broder-Fingert S, Carter AS, Sheldrick RC, Stone WL, Wainer AL. Using virtual multiteam systems to conduct a multisite randomized clinical trial in the part C early intervention system: Benefits, challenges, and lessons learned. Contemp Clin Trials. 2024 Aug; 143:107585.

View in: PubMed
Stopka TJ, Babineau DC, Gibson EB, Knott CE, Cheng DM, Villani J, Wai JM, Blevins D, David JL, Goddard-Eckrich DA, Lofwall MR, Massatti R, DeFiore-Hyrmer J, Lyons MS, Fanucchi LC, Harris DR, Talbert J, Hammerslag L, Oller D, Balise RR, Feaster DJ, Soares W, Zarkin GA, Glasgow L, Oga E, McCarthy J, D'Costa L, Chahine R, Gomori S, Dalvi N, Shrestha S, Garner C, Shadwick A, Salsberry P, Konstan MW, Freisthler B, Winhusen J, El-Bassel N, Samet JH, Walsh SL. Impact of the Communities That HEAL Intervention on Buprenorphine-Waivered Practitioners and Buprenorphine Prescribing: A Prespecified Secondary Analysis of the HCS Randomized Clinical Trial. JAMA Netw Open. 2024 02 05; 7(2):e240132.

View in: PubMed
Teske AJ, Moudgil R, L?pez-Fern?ndez T, Barac A, Brown SA, Deswal A, Neilan TG, Ganatra S, Abdel Qadir H, Menon V, Sverdlov AL, Cheng RK, Makhoul S, Ghosh AK, Szmit S, Zaha V, Addison D, Zhang L, Herrmann J, Chong JH, Agarwala V, Iakobishvili Z, Guerrero P, Yang EH, Leja M, Akhter N, Guha A, Okwuosa TM, Silva CC, Collier P, DeCara J, Bauer B, Lenneman CE, Sadler D. Global Cardio Oncology Registry (G-COR): Registry Design, Primary Objectives, and Future Perspectives of a Multicenter Global Initiative. Circ Cardiovasc Qual Outcomes. 2023 10; 16(10):e009905.

View in: PubMed
Verscaj CP, Velez-Bartolomei F, Bodle E, Chan K, Lyons MJ, Thorson W, Tan WH, Rodig N, Graham JM, Peron A, Quintero-Rivera F, Zackai EH, Thomas MA, Stevens CA, Adam MP, Bird LM, Jones MC, Matalon DR. Characterization of the prenatal renal phenotype associated with 17q12, HNF1B, microdeletions. Prenat Diagn. 2024 02; 44(2):237-246.

View in: PubMed

People

Explore

Similar Concepts

Top Journals